Table 1. Patient and tumor characteristics for all CEC patients treated with definitive CRT (n=37).
Patient characters | Tumor |
|
---|---|---|
Number | Percent (%) | |
Gender | ||
Male | 22 | 59 |
Female | 15 | 41 |
Age | ||
Range | 27-88 | |
Median | 67 | |
Tobacco abuse (lifetime) | ||
Yes | 27 | 73 |
No | 10 | 27 |
Alcohol abuse (lifetime) | ||
Yes | 16 | 43 |
No | 21 | 57 |
T-component | ||
T1 | 5 | 14 |
T2 | 13 | 35 |
T3 | 14 | 38 |
T4 | 5 | 14 |
N-component | ||
N0 | 17 | 46 |
N1 | 14 | 38 |
N2 | 6 | 16 |
N3 | 0 | 0 |
Tumor length (cm) | ||
Range | 2-13 | |
Mean | 4.4 | |
Tumor HPV 16/18 status | ||
HPV positive | 1/19 | 5 |
HPV negative | 18/19 | 95 |
Tumor p16 status | ||
p16 positive | 3/18 | 17 |
p16 negative | 15/18 | 83 |
Radiation dose | ||
<40 Gy | 3 | 8 |
≥40 Gy, <50 Gy | 7 | 19 |
≥50 Gy, <60 Gy | 12 | 32 |
≥60 Gy, <70 Gy | 11 | 30 |
≥70 Gy | 4 | 11 |
Concurrent chemotherapy regimen | ||
CDDP/5-FU | 16 | 43 |
CDDP | 4 | 11 |
CDDP/VP-16 | 6 | 16 |
CDDP/Taxol | 6 | 16 |
Other | 5 | 14 |
CEC, cervical esophageal carcinoma; CRT, chemoradiotherapy.